文献速递关节外科创伤骨科

全膝关节置换术后假体周围骨折的远端股骨置换:澳大利亚骨科协会国家关节置换登记系统回顾

Distal Femoral Replacement for Periprosthetic Fractures After TKA: Australian Orthopaedic Association National Joint Replacement Registry Review.
PubMed 文献 · J Arthroplasty · 2022-03-08

该回顾性登记系统研究分析了澳大利亚骨科协会国家关节置换登记系统中306例因全膝关节置换术后假体周围骨折行远端股骨置换的病例,85%为女性,平均年龄76.4岁。过去五年远端股骨置换数量翻倍,六年累计二次翻修率为12%,翻修最常见原因为感染(37%)和无菌性松动(33%)。患者五年和十年生存率分别为97%和83%,作者认为远端股骨置换是可接受且耐用的治疗选择。

要点

  • 过去五年因假体周围骨折行远端股骨置换的数量翻倍。
  • 六年累计二次翻修率为12%,翻修主因为感染(37%)和无菌性松动(33%)。
  • 患者五年和十年生存率分别为97%和83%;作者认为远端股骨置换是可接受且耐用的选择。

核心结论

  • 国家登记系统回顾发现因全膝关节置换术后假体周围骨折行远端股骨置换日益增多,中期随访假体生存率为88%。
  • 作者认为外科医生可考虑将远端股骨置换作为可接受且耐用的治疗选择。

研究设计与样本

  • 回顾性登记系统回顾,数据来自澳大利亚骨科协会国家关节置换登记系统(AOANJRR)。
  • 共纳入306例因已知初次全膝关节置换术后假体周围骨折行远端股骨置换的病例,85%为女性,平均年龄76.4岁。
  • 采用Kaplan-Meier法估算假体和患者生存率。

主要发现

  • 过去五年因假体周围骨折行远端股骨置换的数量翻倍。
  • 六年累计二次翻修率为12%。
  • 翻修最常见指征为感染(37%)和无菌性松动(33%)。
  • 远端股骨置换后患者五年和十年生存率分别为97%和83%。

临床怎么用

  • 作者认为外科医生可考虑将远端股骨置换作为全膝关节置换术后假体周围骨折可接受且耐用的治疗选择。

局限性

  • 证据等级为Level III(病例系列)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Distal femoral replacement (DFR) is a potential treatment option following periprosthetic fracture (PPF) of a total knee arthroplasty (TKA). However, there is limited literature regarding implant survivorship and complication rates. The aim of this study was to examine patient demographics and trends in usage, implant survivorship and modes of failure, and patient mortality following DFR for PPF captured by a national joint replacement registry. METHODS: A retrospective registry review was performed using data from the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR). In total, 306 DFR were performed for PPF of a known primary TKA. Eighty-five percent of patients were female, and the mean age was 76.4 years. Kaplan-Meier estimates of implant and patient survivorship were performed. RESULTS: The number of DFR performed for PPF has doubled over the past five years. The cumulative percent second revision rate at six years was 12%. The most common indications for revision were infection (37%) and aseptic loosening (33%). Patient survivorship after DFR was 97% and 83% at five and ten years, respectively. CONCLUSION: A national registry review has identified the increasing prevalence of DFR for PPF after primary TKA and demonstrated implant survivorship of 88% at midterm follow-up. Surgeons may consider DFR as an acceptable and durable treatment option. LEVEL OF EVIDENCE: Level III - Case Series.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Aebischer AS, Hau R, de Steiger RN, et al. Distal Femoral Replacement for Periprosthetic Fractures After TKA: Australian Orthopaedic Association National Joint Replacement Registry Review. J Arthroplasty. 2022. PMID: 35271977. doi:10.1016/j.arth.2022.02.115

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。